Aegis Capital Reaffirms Buy on Atai Life Sciences N.V. (ATAI) with $8 Target
Around 193 depression patients, who didn't respond to previous treatment, were part of the Phase 2b trial testing three doses: 0.3 mg, 8 mg, and 12 mg. Not only the 8mg but also the 12mg dose showcased statistically significant improvement in an FDA-accepted measurement of depression, with a healthy side-effect profile.
A close-up of a medical professional providing advice to a patient struggling with opioid use disorder.
The research firm believes these robust results strengthen the company's efforts to proceed to a Phase 3 clinical program, which would result in marketing approval. Going forward, Atai Life Sciences N.V. (NASDAQ:ATAI) plans to schedule a post-Phase 2 meeting with the FDA, with the Phase 3 trial expected to begin only at the end of the upcoming year.
Another noteworthy development is the company's recent $50 million private capital raise, which involved the sale of 18,264,840 common shares with 25% warrant coverage at the market price. Moves like these highlight Atai Life Sciences N.V. (NASDAQ:ATAI)'s capacity to raise cash when needed.
Atai Life Sciences N.V. (NASDAQ:ATAI) is a German clinical-stage biopharmaceutical company that researches, develops, and markets mental health treatments in the United States, Germany, and Canada. With a market capitalization of $587.639 million, the company is committed to healing mental health disorders.
While we acknowledge the potential of ATAI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the .
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Amazon (AMZN)'s AI Push Could Fuel AWS Growth—And Wall Street Is Finally Noticing
Inc. (NASDAQ:) is one of the . On July 10, Citizens JMP analyst Andrew Boone raised the price target on the stock to $285.00 (from $250.00) while maintaining a 'Market Outperform' rating. Firm analysts are of the view that Amazon's AWS opportunity remains underappreciated. 'With reach across 100M + U.S. households, supported by a best-in-class logistics network, and ever-widening selection, we believe Amazon's ability to offer ever faster delivery can continue to unlock demand for additional retail categories and retail growth. "This retail network fuels Amazon's consumer data which is a key driver of its advertising business that we believe can continue to take share given Amazon's growing CTV business. Last, and maybe most important, we believe AI is a key driver of digital transformation and that AI can help drive AWS growth to accelerate, as the AWS opportunity remains underappreciated, in our view.' Inc. (NASDAQ:AMZN) is an American technology company offering e-commerce, cloud computing, and other services, including digital streaming and artificial intelligence solutions. While we acknowledge the potential of AMZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
Nvidia (NVDA) Just Got a Buy Rating From Goldman—Here's Why Analysts Are Bullish
NVIDIA Corporation (NASDAQ:NVDA) is one of the . On July 10, Goldman Sachs analyst James Schneider initiated coverage on the stock with a 'Buy' rating and a price target of $185. Schneider believes that Nvidia is the biggest beneficiary of the ongoing AI infrastructure buildout. The company's broadening customer base is an optimistic signal, along with product leadership and rapid new releases, and an attractive valuation that can drive stock outperformance in the medium term. 'Nvidia is a fabless provider of GPU technology and related software (CUDA), and we see it as the industry standard in accelerated computing. Although stock price action has been choppy due to 'peak concerns' and the growing presence of custom accelerators, we believe that a combination of (1) product leadership and rapid cadence of introductions; (2) broadening of the customer base; (3) early signs of AI monetization; and (4) attractive valuation can drive outperformance versus our coverage.' NVIDIA Corporation (NASDAQ:NVDA) specializes in AI-driven solutions, offering platforms for data centers, self-driving cars, robotics, and cloud services. While we acknowledge the potential of NVDA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.
Yahoo
34 minutes ago
- Yahoo
AMD Gets a $140 Target From Goldman—but Faces Headwinds in AI Race
Advanced Micro Devices, Inc. (NASDAQ:) is one of the . On July 10, Goldman Sachs analyst James Schneider initiated coverage on the stock with a 'Neutral' rating and a price target of $140. The investment bank initiated the U.S. digital semiconductor and electronic design automation software group, highlighting that it is most constructive on merchant silicon and EDA vendors tied to artificial intelligence-related capital spending. 'We believe the AI investment cycle is in a state of transition, with over $350bn in CapEx spent on AI infrastructure,' he said. 'Although monetization has been elusive, we see early signs of incremental revenue and much clearer evidence of cost takeout to justify these investments — and we believe AI CapEx can sustain growth from current levels.' Particularly for AMD, the firm noted that it is a fabless provider of X86-based Server and PC CPUs, custom SoCs, and merchant GPUs. The company has been performing well and has also gained significant market share in the X86 Server CPU and PC CPU markets. Since ARM-based solutions are gaining traction, the firm anticipates AMD's share gains in the Server CPU market to slow down. Meanwhile, AMD's merchant GPU solutions are likely to gain limited market share against Nvidia. Advanced Micro Devices, Inc. (NASDAQ:AMD) develops and sells semiconductors, processors, and GPUs for data centers, gaming, AI, and embedded applications. While we acknowledge the potential of AMD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
